Our law firm is evaluating claims for an Elmiron Lawsuit. Recent studies have found that patients that have been prescribed and use Elmiron have developed Maculopathy, an eye disorder that can lead to blindness. The manufacturer of Elmiron has failed to fully test the drug prior to its release and warn patients of the dangers of using the drug. If you or a loved one is an Elmiron user and have suffered the eye disorder maculopathy, please contact our law firm today as you may be entitled to financial compensation.
What is Elmiron?
Elmiron is a drug prescribed to treat interstitial cystitis, an ailment in the urinary tract system that causes abdominal and pelvic pain. The pain can be chronic or intermittent and the condition can often lead to frequent urination. Interstitial Cystitis is sometimes referred to as bladder pain syndrome that mostly affects women. Elmiron works by attaching itself to the wall of the bladder and providing a buffer between irritating substances and the bladder. However, recent studies have shown users of the drug Elmiron are at increased risk of developing Maculopathy that could also lead to eye injuries and blindness. Medical experts are now recommending that patients that use the drug Elmiron have an ophthalmic examination for early detection of maculopathy.
What are the symptoms of Maculopathy?
As reported in the Journal of Ophthalmology, patients that have been prescribed and used the drug Elmiron have developed Maculopathy. The studies have found that patents that use Elmiron have experienced the follow symptoms:
- Having difficulty reading
- Difficulty of eyes adjusting to darkness
- Difficulty of seeing close objects
- Vision becomes dim
- Spot of vision lost in the field of vision
Consult a Doctor on Medical Issues
Our law firm does not intend, by this web site or otherwise, to dissuade anyone from taking the advice of medical professionals and their doctors. Please consult your doctor, not your lawyer, on matters relating to your health.